The Assessment of Serum Fibronectin Levels as a Potential Biomarker for the Severity of Drug-Sensitive Pulmonary

Shreedhar Kulkarni1, Sumalatha Arunachala1,2,3, Sindaghatta Krishnarao Chaya1

  • 1Department of Respiratory Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India.

PubMed
Abstract

Insights

Tuberculosis patients have lower fibronectin (Fn) levels, which correlate with increased disease severity. Lower Fn may indicate higher mycobacterial load and more extensive lung damage on chest X-rays.

Area of Science:

  • Infectious Diseases
  • Biochemistry
  • Pulmonology

Background:

  • Tuberculosis (TB) remains a significant global health challenge caused by *Mycobacterium tuberculosis* (Mtb).
  • Fibronectin (Fn) is implicated in the attachment of Mtb to host cells.
  • Understanding host factors like Fn levels can provide insights into TB pathogenesis and severity.

Purpose of the Study:

  • To investigate the correlation between serum fibronectin (Fn) levels and disease severity in patients with smear-positive pulmonary tuberculosis (TB).
  • To assess the relationship between Fn levels, mycobacterial load in sputum, and radiological findings on chest X-rays.

Main Methods:

  • Serum Fn levels were measured in 78 newly diagnosed sputum AFB-positive pulmonary TB patients and 11 healthy controls using ELISA.
  • Mycobacterial load was quantified using AFB smear grading (IUATLD classification 0-3).
  • Pulmonary involvement severity was assessed radiologically by the number of chest X-ray zones affected (0-6).

Main Results:

  • Pulmonary TB patients exhibited lower mean Fn levels compared to controls, though not statistically significant.
  • A significant inverse correlation was observed between Fn levels and both AFB smear grade and the number of chest X-ray zones affected.
  • Adjusted Fn levels decreased with increased mycobacterial load and radiological severity, with specific thresholds predicting greater TB severity.

Conclusions:

  • Serum fibronectin (Fn) levels are reduced in tuberculosis patients and correlate negatively with disease severity.
  • Fn levels show potential as a biomarker for assessing TB severity, aiding in early diagnosis and treatment monitoring.
  • These findings highlight the role of fibronectin in TB pathogenesis and its utility in clinical assessment.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
107
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332